![Sadik Kassim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sadik Kassim
Directeur Technique/Scientifique/R&D chez
DANAHER CORPORATION
Profil
Sadik Kassim is currently the Chief Technology Officer at Danaher Corp.
and an Advisor at RA Capital Management LP.
Previously, he was the Executive Director-Process Design at Kite Pharma, Head-Analytical Development at Novartis Pharmaceuticals Corp., Chief Scientific Officer at Mustang Bio, and Chief Technology Officer at Vor Biopharma.
He received his undergraduate degree from Tulane University and his doctorate from LSU Medical School.
Postes actifs de Sadik Kassim
| Sociétés | Poste | Début |
|---|---|---|
| DANAHER CORPORATION | Directeur Technique/Scientifique/R&D | 01/12/2021 |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Consultant / Advisor | - |
Anciens postes connus de Sadik Kassim
| Sociétés | Poste | Fin |
|---|---|---|
| VOR BIOPHARMA INC. | Directeur Technique/Scientifique/R&D | 01/12/2021 |
| KITE PHARMA INC | Corporate Officer/Principal | 01/09/2019 |
| MUSTANG BIO, INC. | Directeur Technique/Scientifique/R&D | 01/01/2019 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | - |
Formation de Sadik Kassim
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Danaher Corp.
 Danaher Corp. Medical SpecialtiesHealth Technology Provides life sciences and diagnostic services | Health Technology |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Lsu Medical School
 Lsu Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
